AI-enabled cardiovascular company Cardio Diagnostics Holdings announced it is partnering with care-navigation platform Navierre to make assessing risk and diagnosing heart diseases more accessible.
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), a leader in artificial intelligence-driven precision cardiovascular medicine tests, today announced the publication of its ...
Cardiovascular disease remains a leading global cause of death, and we break down its pathology, risk factors, and the ...
The diagnostics sector has benefited from a few trends in the past five years that not only have the potential to transform how we screen for cancer but also detect chronic conditions— such as ...
New treatments, care gaps, and cardiac monitoring were major focuses in cardiovascular news this year. The top cardiovascular ...
Coronary heart disease is the leading cause of adult death worldwide. In many cases, quantifying left ventricular ejection fraction (LVEF) – or how much blood the left ventricle pumps out with each ...
Dr. Parag Patel, chief of cardiology at Robert Wood Johnson University Hospital Somerset, joins members of the hospital’s executive team and Cardiology Diagnostic Testing Department to cut the ribbon ...
It's common for patients to schedule an office visit due to symptoms like shortness of breath from doing regular tasks, feeling heart palpitations, experiencing mild chest pain, or feeling weak or ...
A new study finds that cardiovascular diagnostic testing has yet to return to prepandemic levels in some regions of the world, and that excess pandemic-related stress among physicians and testing ...
Objective Evidence on the increased risk of sports-related sudden cardiac arrest and death (SCA/D) and the potential benefit of cardiovascular preparticipation screening (PPS) in children is limited.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback